| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
| 05/05/2010 | CN1788734B Selenium sulfide nano particle additive preparing method and use |
| 05/05/2010 | CN1788730B Gel containing centella general glycoside and sodium hyaluronate for preparing drop and spray agent |
| 05/05/2010 | CN1762390B Burn and boil medicine and its preparation method |
| 05/05/2010 | CN1761450B Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |
| 05/05/2010 | CN1678277B Methods and compositions for treatment of dermal conditions |
| 05/05/2010 | CN1647815B Product with protective function to radiation hazard |
| 05/05/2010 | CN1646151B Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
| 05/05/2010 | CN1568978B Composition for preventing and treating whelk |
| 05/05/2010 | CN1525859B Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN101702880A Highly stable electrolytic water with reduced NMR half line width |
| 05/05/2010 | CN101701032A Quinoxalinone low molecular weight peptide derivative with matrix metalloproteinases inhibition function and preparation method and application thereof |
| 05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
| 05/05/2010 | CN101700396A External medicine for curing alopecia and preparation method thereof |
| 05/05/2010 | CN101700391A Oral traditional Chinese medicine composition for treating psoriasis |
| 05/05/2010 | CN101700360A Chinese medicine prescription for curing bi syndrome |
| 05/05/2010 | CN101700355A Traditional Chinese medicine preparation for treating seborrheic alopecia |
| 05/05/2010 | CN101700333A Traditional Chinese medicine for treating burns and scalds |
| 05/05/2010 | CN101700322A Anti-aging beauty-care capsule and preparation method thereof |
| 05/05/2010 | CN101700316A Traditional Chinese medicine capsule for treating psoriasis |
| 05/05/2010 | CN101700315A Chinese medicine pill for curing leukotrichia |
| 05/05/2010 | CN101700313A Oral Chinese medicine composition for treating alopecia |
| 05/05/2010 | CN101700312A Chinese herbal preparation for curing alopecia areata |
| 05/05/2010 | CN101700285A Application of rumex japonicus in preparing medicines |
| 05/05/2010 | CN101700276A Application of medicinal preparation for preparing medicine used for treating chloasma disease |
| 05/05/2010 | CN101700262A Quality control method of andrographis paniculata dropping pills |
| 05/05/2010 | CN101700259A Hair-growing oil |
| 05/05/2010 | CN101700258A Drug for curing herpes zoster |
| 05/05/2010 | CN101700252A Skin-care cream for treating skin cracks |
| 05/05/2010 | CN101700250A medicine for treating herpes zoster |
| 05/05/2010 | CN101700243A Novel medicine carrying woundplast with treating function |
| 05/05/2010 | CN101700242A Steaming-based moxibustion patch |
| 05/05/2010 | CN101700234A Flucloxacillin sodium suspension and new application thereof |
| 05/05/2010 | CN101700229A Prostaglandin E1 long-circulation fat microsphere preparation for intravenous injection and preparation method thereof |
| 05/05/2010 | CN101700213A Facial mask for removing color flecks |
| 05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709535 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 05/04/2010 | US7709526 Use of cyclolignans and new cyclolignans |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 05/04/2010 | US7709447 Use of spinosyns for wound healing |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 05/04/2010 | US7709027 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 05/04/2010 | CA2417646C Topical gel delivery system |
| 05/04/2010 | CA2406202C Whitening compositions containing ascomycete derived enzyme |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/04/2010 | CA2347981C Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby |
| 05/04/2010 | CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation |
| 05/04/2010 | CA2158134C Supplemented tissue sealant |
| 04/29/2010 | WO2010048264A2 Methods and compositions for the treatment of immunoinflammatory disorders |
| 04/29/2010 | WO2010048154A2 Structured composition comprising an encapsulated active |
| 04/29/2010 | WO2010047381A1 Stable tablet containing 4,5-epoxymorphinan derivative |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046791A1 Phosphodiestarase inhibitors |
| 04/29/2010 | WO2010046458A2 Compositions comprising vitamins |
| 04/29/2010 | WO2010046375A1 Urea-based film-forming solution for treating nail psoriasis |
| 04/29/2010 | WO2010046316A2 A topical composition |
| 04/29/2010 | WO2010045969A1 New synergic association for the treatment of deep skin or mucosa injuries |
| 04/29/2010 | WO2010045862A1 Drug for treating leucoderma |
| 04/29/2010 | WO2010020424A3 Use of glucosylglycerol |
| 04/29/2010 | WO2010011541A3 Topical anti-inflammatory combination |
| 04/29/2010 | WO2010006129A3 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 04/29/2010 | WO2009152493A9 Use of apolipoproteins to decrease inflammation |
| 04/29/2010 | WO2009141541A3 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis |
| 04/29/2010 | WO2009136033A3 Cosmetic use of annexin ii-type proteins for treating dryness of the skin |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105922 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105773 Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization |
| 04/29/2010 | US20100105750 Stable metronidazole gel formulations |
| 04/29/2010 | US20100105721 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS |
| 04/29/2010 | US20100105715 Polymer conjugates of opioid antagonists |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105638 Cosmetic compositions |
| 04/29/2010 | US20100105632 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/29/2010 | US20100105618 Non-Natural Recombinant Gelatins with Enhanced Functionality |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104673 Methods and Compositions for Treatment of Skin Conditions |
| 04/29/2010 | US20100104671 Cosmetic and/or pharmaceutical compositions and their applications |
| 04/29/2010 | US20100104614 Providone compositions for wound healing |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104547 Topical composition for the treatment of allergenic effects |